Champions Oncology (CSBR) Tops Q3 EPS by 37c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of $0.36, $0.37 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $17 million versus the consensus estimate of $12.93 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Futu Holdings Limited (FUTU) Tops Q2 EPS by 23c
- ClearSign Technologies (CLIR) Tops Q2 EPS by 8c
- Coty (COTY) Misses Q4 EPS by 1c, offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
